查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468236

2024-2032 年核医放射性同位素市场（按产品、应用、最终用户和地区划分）

Nuclear Medicine Radioisotopes Market by Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球核医放射性同位素市场规模达73亿美元。癌症盛行率的上升、对核医学的需求不断增加以及各种技术进步是推动市场的一些关键因素。

核子医学放射性同位素是用于各种医疗状况的诊断和治疗过程的放射性物质。这些放射性同位素发出辐射，可以检测和测量辐射，以提供有关体内器官和组织的结构和功能的资讯。它们主要用于诊断和治疗应用。在诊断应用中，放射性同位素用于创建人体内部器官和系统的图像。这使得医疗保健专业人员能够识别异常并诊断癌症、心臟病和神经系统疾病等疾病。另一方面，在治疗应用中，放射性同位素用于对体内的癌细胞或其他异常组织进行标靶放射治疗。此外，核医放射性同位素与传统的诊断和治疗程序相比具有多种优势，因为它们是非侵入性的，不需要手术切口或其他侵入性程序，并且与化疗或放射疗法等治疗相比，副作用和併发症的风险较低。由于这些优点，核医放射性同位素在全球医院广泛使用。

核子医学放射性同位素市场趋势：

该市场主要是由个人癌症盛行率不断上升所推动的。核医放射性同位素广泛应用于癌症诊断解决方案，例如 PET 扫描和治疗疗法。此外，越来越多的老年人口更容易罹患癌症、心臟病和神经系统疾病等慢性疾病，这些疾病需要使用核子医学放射性同位素，这是另一个主要的生长诱导因素。除此之外，各种技术进步导致了核医学放射性同位素新的和改进的诊断和治疗应用的发展。再加上核子医学投资和需求的增加，正在对市场成长产生正面影响。政府和私人组织正大力投资核医技术的研发，进而创造新产品和应用，进而推动市场成长。此外，患者对放射和放射治疗的认识不断增强也推动了市场的发展。此外，医疗保健支出的增加、先进产品变体的推出以及主要参与者进行的研发活动的增加是创造有利市场前景的其他因素。

本报告回答的关键问题：

  • 迄今为止，全球核医放射性同位素市场表现如何，未来几年将如何表现？
  • 全球核医放射性同位素市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球核医学放射性同位素市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的核医放射性同位素市场？
  • 基于产品的市场区隔是什么？
  • 核子医学放射性同位素市场中最具吸引力的产品是什么？
  • 基于应用程式的市场区隔是什么？
  • 核子医学放射性同位素市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 核医放射性同位素市场中哪一个是最具吸引力的最终用户？
  • 全球核医放射性同位素市场竞争格局如何？
  • 全球核医放射性同位素市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球核子医学放射性同位素市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 诊断
    • 市场走向
    • 关键环节
      • 锝-99m (Tc-99m)
      • 镓67
      • 铊201
      • 氟18
      • 其他的
    • 市场预测
  • 疗法
    • 市场走向
    • 关键环节
      • 铼186
      • 碘131
      • 钐-153
      • 钇90
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 心臟病学
    • 市场走向
    • 市场预测
  • 肿瘤学
    • 市场走向
    • 市场预测
  • 甲状腺
    • 市场走向
    • 市场预测
  • 神经病学
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 教育及科研机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bracco SpA
    • Bruce Power Inc.
    • Cardinal Health Inc.
    • China Isotope & Radiation Corporation (China National Nuclear Corporation)
    • Curium Pharma
    • Eckert & Ziegler
    • Nordion (Canada) Inc (Sotera Health Company)
    • NorthStar Medical Radioisotopes, LLC
    • NTP Radioisotopes SOC Ltd
    • Shine Technologies LLC
Product Code: SR112024A7532

The global nuclear medicine radioisotopes market size reached US$ 7.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The rising prevalence of cancer, the escalating demand for nuclear medicines, and various technological advancements represent some of the key factors driving the market.

Nuclear medicine radioisotopes are radioactive substances that are used in diagnostic and therapeutic procedures for various medical conditions. These radioisotopes emit radiation, which can be detected and measured to provide information about the structure and function of organs and tissues in the body. They are mainly utilized for diagnostic and therapeutic applications. In diagnostic applications, radioisotopes are employed to create images of the body's internal organs and systems. This allows healthcare professionals to identify abnormalities and diagnose conditions such as cancer, heart disease, and neurological disorders. On the other hand, in therapeutic applications, radioisotopes are used to deliver targeted radiation therapy to cancer cells or other abnormal tissues in the body. Moreover, nuclear medicine radioisotopes have several advantages over traditional diagnostic and therapeutic procedures as they are non-invasive, do not require surgical incisions or other invasive procedures, and have a lower risk of side effects and complications compared to treatments such as chemotherapy or radiation therapy. Owing to these benefits, nuclear medicine radioisotopes are widely utilized in hospitals across the globe.

Nuclear Medicine Radioisotopes Market Trends:

The market is primarily driven by the growing prevalence of cancer among individuals. Nuclear medicine radioisotopes are widely used in cancer diagnosis solutions such as PET scans and treatment therapies. In addition, the rising geriatric population that is more susceptible to chronic diseases such as cancer, heart disease, and neurological disorders, which require the use of nuclear medicine radioisotopes, represents another major growth-inducing factor. Besides this, various technological advancements have led to the development of new and improved diagnostic and therapeutic applications of nuclear medicine radioisotopes. This, coupled with the increasing investment and demand for nuclear medicines, is positively influencing market growth. Governments and private organizations are investing heavily in the research and development of nuclear medicine technologies, leading to the creation of new products and applications, which in turn is driving the market growth. Moreover, the market is also propelled by the growing patient awareness about radiation and radiation therapy. Furthermore, the rising healthcare expenditure, the launch of advanced product variants, and increasing research and development activities conducted by key players are other factors creating a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nuclear medicine radioisotopes market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, application, and end user.

Product Insights:

Diagnostics

Technetium-99m (Tc-99m)

Gallium-67

Thallium-201

Fluorine-18

Others

Therapeutics

Rhenium-186

Iodine-131

Samarium-153

Yttrium-90

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the product. This includes diagnostics [technetium-99m (Tc-99m), gallium-67, thallium-201, fluorine-18, and others] and therapeutics (rhenium-186, iodine-131, samarium-153, yttrium-90, and others). According to the report, diagnostics (technetium-99m (Tc-99m) represented the largest segment.

Application Insights:

Cardiology

Oncology

Thyroid

Neurology

Others

A detailed breakup and analysis of the nuclear medicine radioisotopes market based on the application has also been provided in the report. This includes cardiology, oncology, thyroid, neurology, and others. According to the report, cardiology accounted for the largest market share.

End User Insights:

Hospitals

Diagnostic Centers

Specialty Clinics

Education and Research Institutes

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the end user. This includes hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for nuclear medicine radioisotopes. Some of the factors driving the North America nuclear medicine radioisotopes market included aging population, technological advancements, rising prevalence of cancer.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global nuclear medicine radioisotopes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bracco S.p.A., Bruce Power Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (China National Nuclear Corporation), Curium Pharma, Eckert & Ziegler, Nordion (Canada) Inc (Sotera Health Company), NorthStar Medical Radioisotopes, LLC, NTP Radioisotopes SOC Ltd.,Shine Technologies LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global nuclear medicine radioisotopes market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine radioisotopes market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine radioisotopes market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the nuclear medicine radioisotopes market?
  • What is the competitive structure of the global nuclear medicine radioisotopes market?
  • Who are the key players/companies in the global nuclear medicine radioisotopes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Radioisotopes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Technetium-99m (Tc-99m)
      • 6.1.2.2 Gallium-67
      • 6.1.2.3 Thallium-201
      • 6.1.2.4 Fluorine-18
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Rhenium-186
      • 6.2.2.2 Iodine-131
      • 6.2.2.3 Samarium-153
      • 6.2.2.4 Yttrium-90
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Thyroid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neurology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Education and Research Institutes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bracco S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Bruce Power Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Cardinal Health Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 China Isotope & Radiation Corporation (China National Nuclear Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Curium Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Eckert & Ziegler
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nordion (Canada) Inc (Sotera Health Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 NorthStar Medical Radioisotopes, LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 NTP Radioisotopes SOC Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shine Technologies LLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Nuclear Medicine Radioisotopes Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Radioisotopes Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Nuclear Medicine Radioisotopes Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Nuclear Medicine Radioisotopes Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Nuclear Medicine Radioisotopes Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Nuclear Medicine Radioisotopes Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Nuclear Medicine Radioisotopes (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Nuclear Medicine Radioisotopes (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Nuclear Medicine Radioisotopes (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Nuclear Medicine Radioisotopes (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Nuclear Medicine Radioisotopes (Thyroid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Nuclear Medicine Radioisotopes (Thyroid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Nuclear Medicine Radioisotopes (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Nuclear Medicine Radioisotopes (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Nuclear Medicine Radioisotopes (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Nuclear Medicine Radioisotopes (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Nuclear Medicine Radioisotopes (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Nuclear Medicine Radioisotopes (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Nuclear Medicine Radioisotopes (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Nuclear Medicine Radioisotopes (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Nuclear Medicine Radioisotopes Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Nuclear Medicine Radioisotopes Industry: Value Chain Analysis
  • Figure 83: Global: Nuclear Medicine Radioisotopes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Radioisotopes Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Nuclear Medicine Radioisotopes Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Radioisotopes Market: Key Players